Eicosanoids mediate microaggregation reactions to bacterial challenge in isolated insect hemocyte preparations

Area of Science:

• Insect immunology
• Cellular defense mechanisms

Background:

• Nodule formation is a primary insect immune response to bacterial infections.
• Eicosanoids are suspected to play a role in hemocyte microaggregation, an early stage of nodulation.
• The specific cellular source of these nodulation-mediating eicosanoids is currently unknown.

Purpose of the Study:

• To investigate whether hemocytes are the source of eicosanoids involved in insect nodulation.
• To elucidate the role of eicosanoids in hemocyte microaggregation in response to bacterial challenge.

Main Methods:

• In vitro study of hemocyte microaggregation in the tobacco hornworm, Manduca sexta.
• Treatment of hemocyte suspensions with phospholipase A(2) inhibitor (dexamethasone) and eicosanoid precursor (arachidonic acid).
• Assessment of microaggregation formation following challenge with Serratia marcescens and application of eicosanoid biosynthesis inhibitors.

Main Results:

• Dexamethasone treatment significantly reduced hemocyte microaggregation.
• The inhibitory effect of dexamethasone was reversed by arachidonic acid but not palmitic acid.
• Filtered media from challenged hemocytes could reverse dexamethasone's effect.
• Most eicosanoid biosynthesis inhibitors reduced microaggregation, while esculetin had no effect.

Conclusions:

• Hemocytes synthesize and secrete eicosanoids that mediate microaggregation.
• This hemocyte-derived eicosanoid production is essential for initiating the nodulation process in insects.
• Findings support the in vivo role of hemocyte-derived eicosanoids in insect immunity.